Polymer Capital Management (HK) LTD
Position in LEGN — Legend Biotech Corp
CIK 1970465
HONG KONG, K3
Position in LEGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,771,235
-$525,281 QoQ
Shares Held
165,209
+1.7% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#58
of 218 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polymer Capital Management (HK) LTD holds $79,733,655 across 15 Biotechnology names. LEGN ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,957 | $19,554,005 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
177,897 | $14,105,453 | |
| 3 | CYTK |
Cytokinetics Inc
|
138,255 | $11,777,943 | |
| 4 | ERAS |
Erasca, Inc.
|
478,020 | $8,757,326 | |
| 5 | LEGN |
Legend Biotech Corp
This page
|
165,209 | $4,771,235 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
263,662 | $3,939,110 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
224,853 | $3,276,108 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
36,800 | $2,999,568 |
All Filings in LEGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,771,235 | 165,209 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $5,296,516 | 162,420 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,751,331 | 162,055 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,254,968 | 36,987 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $934,776 | 28,727 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,038,229 | 41,827 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,328,700 | 30,000 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $300,850 | 5,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||